2m 2m 2m 2m 2m 2m 2m
Aldeyra Therapeu (ALDX)
NASDAQ
$1.40+$0.06 (+4.40%)
Price as of Sep 11, 2026 7:58 PM EDT- $80.8MMarket Cap
- -75.14%1-Year Change
- BiotechnologyIndustry
Aldeyra Therapeu (ALDX)
$1.40+$0.06 (+4.40%)
ALDX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.34 | ||
Change | -$0.12 (-8.22%) | ||
Open | $1.48 | ||
High | $1.48 | ||
Low | $1.33 | ||
Previous Close | $1.46 | ||
Volume | 1,565,518 | ||
30-Day Average Volume | 719,253 | ||
1-Week Change | -9.46% | ||
1-Month Change | -11.26% | ||
1-Year Change | -75.14% | ||
3-Year Change | -81.47% | ||
5-Year Change | -84.77% | ||
Fundamentals | |||
Shares Outstanding | 60.3M | ||
Total Assets | $47.5M | ||
Market Cap | $80.8M | ||
Enterprise Value | $100.7M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$5.5M | ||
Free Cash Flow | -$4.6M | ||
EBIT | -$5.5M | ||
EBITDA | -$5.4M | ||
Net Working Capital | $37.7M | ||
EPS | -$0.09 | ||
Enterprise Value/EBITDA | -19 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -15 | ||
PEG | 0 | ||
Price/Free Cash Flow | -18 | ||
Price/Operating Cash Flow | -18 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue